Misinformation about PCOS is widespread, creating challenges for women around the world. Real patient testimonies help bring clarity and inspire meaningful change, guiding the way toward science-based, patient-centred solutions.
Polycystic Ovary Syndrome (PCOS) affects millions of women worldwide, yet it remains highly misunderstood. For many, the journey to diagnosis is long and confusing. And, once diagnosis finally comes, a new challenge begins: navigating the avalanche of contradictory advice. The internet in general and social media in particular are full of miracle diets, supplements, or quick fixes for PCOS, often without scientific evidence. This flood of misinformation leaves patients even more lost, with little clarity about what PCOS really means for their health.
This confusion is part of a bigger picture. For decades, women’s health has been under-prioritised in medical research. Change is underway, with the EU placing women’s health at the heart of its research agenda, but much remains to be done.
In June 2025, The Guardian published a personal story that shed light on the reality of living with PCOS. The testimony of Charlie Brinkhurst-Cuff, diagnosed with PCOS at 30, highlights what so many women live through: uncertainty, frustration, and the urgent need for trustworthy, science-based solutions.
“My Instagram feed is filled with medically unqualified influencers. Sorting through all that to figure out which nutritionists and health professionals to pay attention to, in the absence of adequate support from the doctors and nurses who gave me that initial assessment and diagnosis, has been a battle”, Charlie Brinkhurst-Cuff.
Real stories like hers remind us why initiatives like SPIOMET4HEALTH are so critical: to replace myths with evidence, and isolation with support.
Discover the real stories of women taking part in the SPIOMET4HEALTH clinical trial
PCOS: A condition surrounded by confusion
The public conversation around PCOS has grown in recent years, yet many patients still report:
- – Unclear diagnoses or delays in identification.
- – Fragmented care, with hormonal, metabolic, and mental health issues treated separately.
- – Inconsistent information about nutrition, fertility, and long-term risks.
- – A flood of non-scientific advice, especially online.
How can this change? Healthcare and research communities need to do more to provide clarity, compassion, and reliable answers — especially in the early stages of the condition.
“I feel incredibly thankful that I have been diagnosed in an era where there are women who are fighting for the recognition and evidence-based treatment of PCOS. We are not at a loss. We are at the bright beginning”.
SPIOMET4HEALTH: Focused research for adolescents
SPIOMET4HEALTH is a research project funded by the European Union’s Horizon 2020 programme. We are conducting a multi-country clinical trial to evaluate a new treatment for PCOS. Unlike standard treatments that just suppress symptoms, SPIOMET4HEALTH aims to address the root causes of the condition: hormone imbalance, metabolic dysfunction, and ectopic fat accumulation. Our goal is not only to reduce symptoms like irregular cycles or acne, but to improve long-term health outcomes and quality of life of women with PCOS.
Beyond clinical research, at SPIOMET4HEALTH we are committed to raising the voices of women living with PCOS and providing them with the support they deserve. By sharing real stories, we aim to counter misinformation, foster understanding, and build a community where women feel informed and supported. And, by creating content that is useful, reliable, and empowering, we aim to bridge the gap between clinical research and everyday life, providing meaninflul and accesible information.
Visit our news section
Why PCOS research matters now more than ever
PCOS real stories are a valuable reminder that lived experience must inform scientific research—and that research must respond to real needs. When individuals share their PCOS journeys, including the confusion and misinformation they encounter, they shine a light on the gaps that projects like ours are working to fill.
So, how is SPIOMET4HEALTH is helping?
1. Scientific rigor
Our randomized, placebo-controlled Phase II trial is being conducted across seven European countries. Every step of the process—from participant selection to long-term follow-up—is designed to produce high-quality data that can inform clinical practice.
2. Focus on early intervention
By starting treatment early, we aim to reduce the risk of long-term complications like infertility, insulin resistance, and cardiovascular disease.
3. Beyond symptoms
Our trial includes mechanisms to evaluate how treatment affects wellbeing, confidence, and quality of life.
4. Transparency
As a public research initiative, SPIOMET4HEALTH is committed to open science. All results will be published and shared with the medical community, patients, and policy makers alike.
If you want to find out more about the SPIOMET4HEALTH project, discover our website, read the experiences from our clinical trial participants or contact us.
This post highlights an article published by The Guardian on 22 June 2025, titled “I was diagnosed with PCOS – and was soon drowning in misinformation”. You can read it in full here.